Anti-connexin antibody formulations | Patent Publication Number 20220033492

US 20220033492 A1

Patent NumberUS 11912764 B2

Application Number17390635

Filled DateJul 30, 2021

Priority DateJul 31, 2020

Publication DateFeb 3, 2022

Original AssigneeAlamab Therapeutics Inc.

Current AssigneeAlamab Therapeutics Inc.

Inventor/ApplicantsYanfeng Zhang

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.